Investor directory
Medicxi
Medicxi specializes in biotechnology investments with a focus on innovative therapeutic solutions.
What they invest in
Geographies
EUUS
The facts
- Typical cheque
- €1M – €75M
- Headquarters
- London, United Kingdom
- Founded
- 2016
Portfolio
Phathom Pharmaceuticals (NAS: PHAT)ProfoundBioCurevo VaccineD3 BioViceBioVaxcyte (NAS: PCVX)Rivus PharmaceuticalsAura Biosciences (NAS: AURA)Breakpoint TherapeuticsOttimo PharmaAldena TherpeuticsXenikosCheckmate PharmaceuticalsLeviceptAltesa BioSciencesFore BiotherapeuticsAlys PharmaceuticalsVaderis TherapeuticsDiasomeSynthorxCritical PressureVersanis BioApcinteXDivide & Conquer
and 26 more
Does Medicxi fit your round?
Oka scores this fund against your actual raise — stage, sector, cheque size and traction — and shows you who can introduce you.
Check your matchAre you Medicxi? Tell us what to correct and we will update it — or ask us to remove the entry.